MAPT and Alzheimer disease: Subsequently, K18 tau aggregates have been unilaterally injected into the LC of PS19 tau transgenic mice [30], which present with the P301S mutation [31], effectively seeding pathology, which spreads to anatomically connected areas similarly to what is seen in AD, and resulted in cell loss in the injected LC [30].